Compare $ANGO vs $NPCE | Chartloom

Compare

$ANGO vs $NPCE

AngioDynamics Inc · Neuropace Inc

ANGO

AngioDynamics Inc

NPCE

Neuropace Inc

Compare $ANGO vs $NPCE

Comparing AngioDynamics Inc and Neuropace Inc

ANGOAngioDynamics Inc

NPCENeuropace Inc

ANGOAngioDynamics Inc

Market cap

$476M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

8.2%

YTD performance

-9.1%

52W performance

3.6%

FCF yield

-0.3%

NPCENeuropace Inc

Market cap

$432M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.83x

Rev growth (TTM)

11.6%

YTD performance

-16.5%

52W performance

13.8%

FCF yield

-2.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ANGO

NPCE

Detailed metrics comparison

ANGO

AngioDynamics Inc

NPCE

Neuropace Inc

Market Cap

ANGO$476M

NPCE$432M

Enterprise Value

ANGO$442M

NPCE$478M

Price

ANGO$11.52

NPCE$12.67

P/E Ratio

ANGON/A

NPCEN/A

P/S Ratio

ANGO1.46x

NPCE4.37x

EV/Sales

ANGO1.36x

NPCE4.84x

EV/EBITDA

ANGO631.64x

NPCE0.00x

P/B Ratio

ANGO3.72x

NPCE36.68x

P/FCF Ratio

ANGON/A

NPCEN/A

EV/FCF

ANGO-333.70x

NPCE-41.21x

PEG Ratio

ANGON/A

NPCEN/A

Forward P/E (NTM)

ANGON/A

NPCEN/A

Forward P/S (NTM)

ANGON/A

NPCE3.83x

Revenue (TTM)

ANGO$325M

NPCE$99M

Revenue Growth (YoY)

ANGO8.2%

NPCE11.6%

Forward Rev Growth

ANGO5.3%

NPCE22.0%

Gross Margin (TTM)

ANGO55.7%

NPCE79.6%

Operating Margin (TTM)

ANGO0.0%

NPCE0.0%

EBITDA Margin (TTM)

ANGO0.2%

NPCE-15.0%

Net Margin (TTM)

ANGO-10.1%

NPCE-19.3%

FCF Margin (TTM)

ANGO-0.4%

NPCE-11.7%

Net Income (TTM)

ANGO$-33M

NPCE$-19M

FCF (TTM)

ANGO$-1M

NPCE$-12M

EPS (TTM)

ANGO-$0.79

NPCE-$0.56

ROE (TTM)

ANGO-2101.0%

NPCE-11968.0%

ROA (TTM)

ANGO-1382.0%

NPCE-1871.0%

ROIC (TTM)

ANGO-2032.0%

NPCE-2552.0%

Cash

ANGO$34M

NPCE$13M

Debt

ANGO$0

NPCE$59M

Net Cash/Debt

ANGO$34M

NPCE$-46M

Current Ratio (TTM)

ANGO2.19x

NPCE4.94x

Quick Ratio (TTM)

ANGO1.37x

NPCE3.82x

Debt/Equity (TTM)

ANGO0.03x

NPCE4.97x

Debt/Assets (TTM)

ANGO0.0%

NPCE0.0%

Interest Coverage (TTM)

ANGON/A

NPCEN/A

Net Debt/EBITDA (TTM)

ANGO0.00x

NPCE0.00x

Beta

ANGO0.23

NPCE1.95

52W Performance

ANGO3.6%

NPCE13.8%

YTD Performance

ANGO-9.1%

NPCE-16.5%

% from 52W High

ANGO-29.3%

NPCE-35.4%

% from 52W Low

ANGO22.7%

NPCE37.4%

Asset Turnover (TTM)

ANGO1.20x

NPCE0.97x

FCF Yield (TTM)

ANGO-0.3%

NPCE-2.7%

Earnings Yield (TTM)

ANGO-6.9%

NPCE-4.4%

Dividend Yield (TTM)

ANGON/A

NPCEN/A

Rule of 40

ANGO7.8

NPCE-0.2

EV/GP/RG

ANGO0.46

NPCE0.40

Ticker research

View ANGO research View NPCE research

Metric	ANGO AngioDynamics Inc	NPCE Neuropace Inc
Market & Valuation
Market Cap	$476M	$432M
Enterprise Value	$442M	$478M
Price	$11.52	$12.67
P/E Ratio	N/A	N/A
P/S Ratio	1.46x	4.37x
EV/Sales	1.36x	4.84x
EV/EBITDA	631.64x	0.00x
P/B Ratio	3.72x	36.68x
P/FCF Ratio	N/A	N/A
EV/FCF	-333.70x	-41.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.83x
Revenue & Growth
Revenue (TTM)	$325M	$99M
Revenue Growth (YoY)	8.2%	11.6%
Forward Rev Growth	5.3%	22.0%
Profitability
Gross Margin (TTM)	55.7%	79.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.2%	-15.0%
Net Margin (TTM)	-10.1%	-19.3%
FCF Margin (TTM)	-0.4%	-11.7%
Net Income (TTM)	$-33M	$-19M
FCF (TTM)	$-1M	$-12M
EPS (TTM)	-$0.79	-$0.56
ROE (TTM)	-2101.0%	-11968.0%
ROA (TTM)	-1382.0%	-1871.0%
ROIC (TTM)	-2032.0%	-2552.0%
Financial Health
Cash	$34M	$13M
Debt	$0	$59M
Net Cash/Debt	$34M	$-46M
Current Ratio (TTM)	2.19x	4.94x
Quick Ratio (TTM)	1.37x	3.82x
Debt/Equity (TTM)	0.03x	4.97x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	1.95
52W Performance	3.6%	13.8%
YTD Performance	-9.1%	-16.5%
% from 52W High	-29.3%	-35.4%
% from 52W Low	22.7%	37.4%
Efficiency & Yields
Asset Turnover (TTM)	1.20x	0.97x
FCF Yield (TTM)	-0.3%	-2.7%
Earnings Yield (TTM)	-6.9%	-4.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	7.8	-0.2
EV/GP/RG	0.46	0.40
Ticker research	View ANGO research	View NPCE research

Valuation

P/S Ratio

ANGO

1.46x

NPCE

4.37x

EV/FCF

ANGO

-333.70x

NPCE

-41.21x

Growth & revenue

Revenue Growth TTM

NPCE

11.6%

ANGO

8.2%

Forward Revenue Growth

NPCE

22.0%

ANGO

5.3%

Profitability & performance

Gross Margin

NPCE

79.6%

ANGO

55.7%

ROE

ANGO

-2101.0%

NPCE

-11968.0%

FCF Yield %

ANGO

-0.3%

NPCE

-2.7%

52-Week Performance

NPCE

13.8%

ANGO

3.6%

Detailed metrics comparison

ANGO

AngioDynamics Inc

NPCE

Neuropace Inc

Market Cap

ANGO$476M

NPCE$432M

Enterprise Value

ANGO$442M

NPCE$478M

Price

ANGO$11.52

NPCE$12.67

P/E Ratio

ANGON/A

NPCEN/A

P/S Ratio

ANGO1.46x

NPCE4.37x

EV/Sales

ANGO1.36x

NPCE4.84x

EV/EBITDA

ANGO631.64x

NPCE0.00x

P/B Ratio

ANGO3.72x

NPCE36.68x

P/FCF Ratio

ANGON/A

NPCEN/A

EV/FCF

ANGO-333.70x

NPCE-41.21x

PEG Ratio

ANGON/A

NPCEN/A

Forward P/E (NTM)

ANGON/A

NPCEN/A

Forward P/S (NTM)

ANGON/A

NPCE3.83x

Revenue (TTM)

ANGO$325M

NPCE$99M

Revenue Growth (YoY)

ANGO8.2%

NPCE11.6%

Forward Rev Growth

ANGO5.3%

NPCE22.0%

Gross Margin (TTM)

ANGO55.7%

NPCE79.6%

Operating Margin (TTM)

ANGO0.0%

NPCE0.0%

EBITDA Margin (TTM)

ANGO0.2%

NPCE-15.0%

Net Margin (TTM)

ANGO-10.1%

NPCE-19.3%

FCF Margin (TTM)

ANGO-0.4%

NPCE-11.7%

Net Income (TTM)

ANGO$-33M

NPCE$-19M

FCF (TTM)

ANGO$-1M

NPCE$-12M

EPS (TTM)

ANGO-$0.79

NPCE-$0.56

ROE (TTM)

ANGO-2101.0%

NPCE-11968.0%

ROA (TTM)

ANGO-1382.0%

NPCE-1871.0%

ROIC (TTM)

ANGO-2032.0%

NPCE-2552.0%

Cash

ANGO$34M

NPCE$13M

Debt

ANGO$0

NPCE$59M

Net Cash/Debt

ANGO$34M

NPCE$-46M

Current Ratio (TTM)

ANGO2.19x

NPCE4.94x

Quick Ratio (TTM)

ANGO1.37x

NPCE3.82x

Debt/Equity (TTM)

ANGO0.03x

NPCE4.97x

Debt/Assets (TTM)

ANGO0.0%

NPCE0.0%

Interest Coverage (TTM)

ANGON/A

NPCEN/A

Net Debt/EBITDA (TTM)

ANGO0.00x

NPCE0.00x

Beta

ANGO0.23

NPCE1.95

52W Performance

ANGO3.6%

NPCE13.8%

YTD Performance

ANGO-9.1%

NPCE-16.5%

% from 52W High

ANGO-29.3%

NPCE-35.4%

% from 52W Low

ANGO22.7%

NPCE37.4%

Asset Turnover (TTM)

ANGO1.20x

NPCE0.97x

FCF Yield (TTM)

ANGO-0.3%

NPCE-2.7%

Earnings Yield (TTM)

ANGO-6.9%

NPCE-4.4%

Dividend Yield (TTM)

ANGON/A

NPCEN/A

Rule of 40

ANGO7.8

NPCE-0.2

EV/GP/RG

ANGO0.46

NPCE0.40

Ticker research

View ANGO research View NPCE research

Metric	ANGO AngioDynamics Inc	NPCE Neuropace Inc
Market & Valuation
Market Cap	$476M	$432M
Enterprise Value	$442M	$478M
Price	$11.52	$12.67
P/E Ratio	N/A	N/A
P/S Ratio	1.46x	4.37x
EV/Sales	1.36x	4.84x
EV/EBITDA	631.64x	0.00x
P/B Ratio	3.72x	36.68x
P/FCF Ratio	N/A	N/A
EV/FCF	-333.70x	-41.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.83x
Revenue & Growth
Revenue (TTM)	$325M	$99M
Revenue Growth (YoY)	8.2%	11.6%
Forward Rev Growth	5.3%	22.0%
Profitability
Gross Margin (TTM)	55.7%	79.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.2%	-15.0%
Net Margin (TTM)	-10.1%	-19.3%
FCF Margin (TTM)	-0.4%	-11.7%
Net Income (TTM)	$-33M	$-19M
FCF (TTM)	$-1M	$-12M
EPS (TTM)	-$0.79	-$0.56
ROE (TTM)	-2101.0%	-11968.0%
ROA (TTM)	-1382.0%	-1871.0%
ROIC (TTM)	-2032.0%	-2552.0%
Financial Health
Cash	$34M	$13M
Debt	$0	$59M
Net Cash/Debt	$34M	$-46M
Current Ratio (TTM)	2.19x	4.94x
Quick Ratio (TTM)	1.37x	3.82x
Debt/Equity (TTM)	0.03x	4.97x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	1.95
52W Performance	3.6%	13.8%
YTD Performance	-9.1%	-16.5%
% from 52W High	-29.3%	-35.4%
% from 52W Low	22.7%	37.4%
Efficiency & Yields
Asset Turnover (TTM)	1.20x	0.97x
FCF Yield (TTM)	-0.3%	-2.7%
Earnings Yield (TTM)	-6.9%	-4.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	7.8	-0.2
EV/GP/RG	0.46	0.40
Ticker research	View ANGO research	View NPCE research